Prof. Yun Hou | Binzhou Medical University | China
Hou Yun is an Associate Professor and Master’s Supervisor at Binzhou Medical University, recognized for his advancing contributions to neurodegeneration research, stem cell applications, and aging-related therapeutics. His work integrates molecular biology, neuropharmacology, and regenerative medicine to uncover mechanisms underlying neuronal survival, neuroinflammation, and degeneration, while also exploring stem cell-based interventions for anti-aging. As a member of the Youth Committee of the Shandong Anatomical Society and a reviewer for the National Natural Science Foundation of China, he plays an active role in the scientific community. His recent publications provide insight into targeted therapeutic pathways, including studies revealing how novel pyrimidine derivatives suppress glioma growth via miR-873-3p regulation and how hydroxytyrosol counteracts pollutant-induced NF-κB pathway activation, oxidative stress, and neuronal apoptosis. With 51 published documents, an h-index of 21, and 1,658 citations across 1,354 citing documents, his body of work reflects sustained scientific impact and productivity in neurodegenerative disease mechanisms and intervention strategies. His ongoing research continues to advance understanding of neuronal resilience, disease-modifying pathways, and innovative biomedical approaches to combat aging and neurodegeneration.
Featured Publications
Lavender: phytochemistry, pharmacology, cross-disciplinary applications, and clinical efficacy. (2025). Phytomedicine.
Novel 3,4-dihydronaphthalen-1(2H)-one derivatives promote apoptosis and inhibit migration of hepatocellular carcinoma cells via inhibition of NF-κB and MAPK signaling pathways. (2025). European Journal of Medicinal Chemistry.
Hydroxytyrosol inhibits BPS-induced NF-κB signaling pathway activation, mitigates oxidative stress, and reduces neuronal apoptosis. (2025). Journal of Biochemical and Molecular Toxicology.
Elucidating the mechanism of 1,4,5,6,7,8-hexahydropyrido[4,3-d]pyrimidine-induced inhibition of glioma growth through miR-873-3p. (2025). Molecular Carcinogenesis.
The crystal structure of methyl ((4-aminobenzyl)sulfonyl)-D-prolinate, C13H18N2O4S. (2024). Zeitschrift für Kristallographie – New Crystal Structures.